Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies (Q45246419)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies |
scientific article |
Statements
1 reference
Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies (English)
1 reference
E Claire Dees
1 reference
Neil L Spector
1 reference
Wenle Xia
1 reference
Howard Burris
1 reference
Herbert Hurwitz
1 reference
Afshin Dowlati
1 reference
Bert O'Neil
1 reference
Beth Overmoyer
1 reference
Paul K Marcom
1 reference
Kimberly L Blackwell
1 reference
Deborah A Smith
1 reference
Kevin M Koch
1 reference
Andrew Stead
1 reference
Steven Mangum
1 reference
Matthew J Ellis
1 reference
Leihua Liu
1 reference
Albert K Man
1 reference
Troy M Bremer
1 reference
Jennifer Harris
1 reference
Sarah Bacus
1 reference
31 January 2005
1 reference
1 reference
23
1 reference
11
1 reference
2502-2512
1 reference
Identifiers
1 reference
1 reference